Get a Quote

Albendazole API (CAS 54965-21-8)
CAS NO.: 54965-21-8
Chemical Formula: C17H16ClN3O
Molecular Weight: 265.3310
DMF&GMP status: Please contact us for details
Description:
Albendazole is medication used for the treatment of a variety of parasitic worm infestations. Albendazole is useful for giardiasis, trichuriasis, filariasis, neurocysticercosis, hydatid disease, pinworm disease, and ascariasis, among others. It is taken by mouth.

Common side effects of Albendazole include nausea, abdominal pains, and headaches. Potentially serious side effects include bone marrow suppression which usually improves on stopping the medication. Liver inflammation has been reported and those with prior liver problems are at greater risk. It is pregnancy category C in the United States and category D in Australia, meaning it may cause harm if taken by a pregnant women. Albendazole is a broad-spectrum antihelminthic agent of the benzimidazole type.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
ALBENDAZOLETABLET; ORAL200MGALBENZAAMEDRA PHARMS LLC
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
Exclusive Data
Exclusivity Code Exclusivity Expiration